Search

Displaying results 3311 - 3320 of 4859 in total
  1. Drug

    Teverelix

    go.drugbank.com/drugs/DB05624
    Investigational

    It has reached phase II clinical trials.

  2. Drug

    Alcuronium

    go.drugbank.com/drugs/DB13648
    Experimental

    It is used as an anesthesia adjuvant.

  3. Drug

    Parathyroid hormone

    go.drugbank.com/drugs/DB05829
    ApprovedInvestigational

    Available as Preotact, it is an identical form of human recombinant hormome which produced as a fusion protein undergoeing post-translational processing involving the cleavage of the OmpA leader sequence

  4. Drug

    Mavorixafor

    go.drugbank.com/drugs/DB05501
    ApprovedInvestigational

    [L50642] It was first approved by the FDA on April 30, 2024, for the treatment of warts, hypogammaglobulinemia, infections, and myelokathexis (WHIM) syndrome, a genetic immunodeficiency disorder characterized

  5. Drug

    3-hydroxyanthranilic acid

    go.drugbank.com/drugs/DB03644
    Experimental

    It may be a free radical scavenger and a carcinogen.

  6. Drug

    KF-0210

    go.drugbank.com/drugs/DB17476
    Investigational

    It is being investigated for cancers.

  7. Drug

    Apararenone

    go.drugbank.com/drugs/DB15024
    Investigational

    Apararenone is under investigation in clinical trial NCT02531568 (Drug Interaction Study of Warfarin and MT-3995).

  8. Drug

    Cusatuzumab

    go.drugbank.com/drugs/DB15100
    Investigational

    [A241045] It is currently being investigated in the Phase 2 CULMINATE trial, in combination with [azacitidine], for the treatment of newly-diagnosed acute myeloid leukemia (AML) and high-risk myelodysplastic

  9. Drug

    Bamlanivimab

    go.drugbank.com/drugs/DB15718
    ApprovedInvestigational

    [A224044, L20974] It is set to enter phase 3 clinical trials. … A224039, L15311, L15316, L20979] AbCellera initially discovered bamlanivimab in collaboration with the National Institute of Allergy and Infectious Diseases (NIAID), and subsequently further developed it

  10. Drug

    Renzapride

    go.drugbank.com/drugs/DB04917
    Investigational

    It has been suggested that renzapride is effective in the treatment of irritable bowel syndrome with alternating stool pattern. It is being developed by Alizyme of the UK.